生華生物科技股份有限公司 SENHWA BIOSCIENCES INC.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Senhwa Biosciences CX-4945 Granted Orphan Drug Designation by the US FDA in Cholangiocarcinoma 2017-01-04 22:00
Senhwa Biosciences Appoints Lucas S. Chang as General Counsel 2016-12-14 22:00
Senhwa CX-4945 Phase I Clinical Trial Results Accepted for Presentation at the 2017 ASCO Gastrointestinal Cancers Symposium 2016-12-06 22:00
1 2 3